Elvitegravir: uses, dosing, side effects & brands
Elvitegravir is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Tablet
- Sold as
- Vitekta
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
Every elvitegravir product we track (1)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
Only one: Vitekta.
Combination products containing elvitegravir
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
Elvitegravir and breastfeeding
From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.
Full LactMed record for elvitegravir: levels in milk, effects in breastfed infants, and the drugs it would consider insteadNo published information is available on the use of elvitegravir during breastfeeding. An alternate agent may be preferred. Achieving and maintaining viral suppression with antiretroviral therapy decreases breastfeeding transmission risk to less than 1%, but not zero. Individuals with HIV who are on antiretroviral therapy with a sustained undetectable viral load and who choose to breastfeed should be supported in this decision. If a viral load is not suppressed, banked pasteurized donor milk or formula is recommended.
National Institute of Child Health and Human Development, record revised July 15, 2024. LactMed states its information is not a substitute for professional judgement.
What people report to the FDA about elvitegravir
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,527 reports naming elvitegravir, and the FDA flagged 94% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- foetal exposure during pregnancy111 reports
- maternal exposure during pregnancy87 reports
- pathogen resistance61 reports
- virologic failure60 reports
- abortion spontaneous53 reports
- drug resistance50 reports
- osteoporosis49 reports
- exposure during pregnancy40 reports
Read these as a signal, not a rate. A report does not mean elvitegravir caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 25, 2026.
Related calculators
Frequently asked questions
Can you take elvitegravir with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run elvitegravir against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What forms does elvitegravir come in?
Across the brands we track, elvitegravir is currently marketed as tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic elvitegravir?
We do not currently list a generic-labelled elvitegravir product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Elvitegravir: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/elvitegravir
- MLA
- “Elvitegravir: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/elvitegravir.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for elvitegravir on DailyMed (NIH) ↗.